201 related articles for article (PubMed ID: 6186610)
1. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
Khandwala A; Coutts SM; Dally-Meade V; Jariwala N; Huang FC
Int Arch Allergy Appl Immunol; 1983; 70(4):311-20. PubMed ID: 6186610
[TBL] [Abstract][Full Text] [Related]
2. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
[TBL] [Abstract][Full Text] [Related]
3. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
Khandwala A; Dally-Meade V; Jariwala N; Huang F
Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
[TBL] [Abstract][Full Text] [Related]
4. RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds. Novel inhibitors of histamine release from rat mast cells and human basophils.
Khandwala A; Coutts S; Dally-Meade V; Jariwala N; Musser J; Brown R; Jones H; Loev B; Weinryb I
Biochem Pharmacol; 1983 Nov; 32(22):3325-33. PubMed ID: 6197075
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
[TBL] [Abstract][Full Text] [Related]
6. Antiallergic activity profile in vitro of RHC 2963 and related compounds.
Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Youssefyeh RD
Int J Immunopharmacol; 1983; 5(6):491-502. PubMed ID: 6198298
[TBL] [Abstract][Full Text] [Related]
7. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). I. Effect on release of histamine in vitro from rat peritoneal mast cells, guinea pig lung slices and human basophils.
Khandwala A; Coutts SM; Weinryb I
Int Arch Allergy Appl Immunol; 1983; 70(4):295-302. PubMed ID: 6186608
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activity profile of RHC 2851: a new orally effective antiallergic agent.
Khandwala A; Carlson R; Dally-Meade V; Donigi-Ruzza D
J Immunopharmacol; 1983; 5(4):311-32. PubMed ID: 6199431
[TBL] [Abstract][Full Text] [Related]
9. Antiallergic activity of tiaramide (RHC 2592-A).
Khandwala A; Coutts S; Weinryb I
Int Arch Allergy Appl Immunol; 1982; 69(2):159-68. PubMed ID: 6179887
[TBL] [Abstract][Full Text] [Related]
10. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. I. A lack of correlation between inhibition of cyclic nucleotide phosphodiesterases and antigen-induced release of histamine from rat mast cells.
Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Jariwala N; Huang F; Musser J; Brown R; Loev B; Weinryb I
Int Arch Allergy Appl Immunol; 1984; 73(1):56-64. PubMed ID: 6198287
[TBL] [Abstract][Full Text] [Related]
11. Extracellular guanosine 3',5'-cyclic monophosphate and disodium cromoglycate share a similar spectrum of activity in the inhibition of histamine release from isolated mast cells and basophils.
Mackay GA; Pearce FL
Int Arch Allergy Immunol; 1996 Mar; 109(3):258-65. PubMed ID: 8620095
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of traxanox sodium on IgE-mediated histamine release from passively-sensitized mast cells of the rat in vitro.
Goto K; Hisadome M; Terasawa M
Int Arch Allergy Appl Immunol; 1982; 68(4):332-7. PubMed ID: 6178699
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of immediate hypersensitivity reactions in the rat by ICI 74,917 and disodium cromoglycate.
Evans DP; Marshall PW; Thomson DS
Int Arch Allergy Appl Immunol; 1975; 49(4):417-27. PubMed ID: 51008
[TBL] [Abstract][Full Text] [Related]
14. Actions and cross-reactivity of antiallergic agents and a calcium channel antagonist on rat peritoneal mast cells. Difference in the action mechanisms and cross-reactivity among the agents.
Tanizaki Y; Ohtani J; Kimura I
Agents Actions; 1992 Sep; 37(1-2):8-15. PubMed ID: 1280907
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of histamine release by antiallergic drugs.
Nagai H; Kelly K; Sehon AH
Int Arch Allergy Appl Immunol; 1978; 56(4):307-15. PubMed ID: 75849
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological studies on oxatomide: (4) Effect on the histamine release from isolated rat peritoneal exudate cells (PEC) and lung slices].
Ohmori K; Ishii H; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):441-9. PubMed ID: 6186585
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies on the mechanism of action of a new antiallergic, Ro 21-7634.
Welton AF; Hope WC; Crowley HJ; Salvador RA
Agents Actions; 1981 Jul; 11(4):345-51. PubMed ID: 6169263
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanism of tachyphylaxis to disodium cromoglycate.
Sung CP; Saunders HL; Krell RD; Chakrin LW
Int Arch Allergy Appl Immunol; 1977; 55(1-6):374-84. PubMed ID: 73515
[TBL] [Abstract][Full Text] [Related]
19. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
Nabe T; Yamamura H; Kohno S; Ohata K
Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes.
Chand N; Pillar J; Diamantis W; Sofia RD
Int Arch Allergy Appl Immunol; 1985; 77(4):451-5. PubMed ID: 2410374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
